Emerging Technologies in Healthcare

Learn about the promising technological advancements impacting future human disease treatments

Date icon

15 Nov 2024

Attendance icon

On location or online

Language icon

English

Price icon
Online 6,000 DKK ex VAT
On location 6,500 DKK ex VAT
50% DISCOUNT FOR PUBLIC INSTITUTIONS

Summary

Do you need knowledge about the latest developments in healthcare technology? If so, our one-day course on emerging technologies in healthcare is perfect for you.

You will get insights into some of the most promising technologies and how they can improve patient outcomes in the future.


We will delve into the use and benefits of the following technologies:
  1. Gene therapies including CRISPR. You’ll learn about the latest advancements in gene editing and how they can be used to treat certain severe, inherited disorders such as cystic fibrosis and hemophilia.
  2. Stem cell therapy: You’ll learn what stem cell therapy is, how it works, and how this technology can be used to treat a variety of diseases, including potentially diabetes 1, Alzheimer’s and Parkinson’s disease.
  3. RNA based therapeutics: You’ll learn about the latest advancements in RNA based therapeutics: which diseases you can treat, how this mode of action functions, and what to expect in the future.
  4. Precision medicine: You’ll learn what precision medicine is, how it works, and how it can be used to improve patient outcomes.
  5. AI in drug development and patient treatment: Artificial Intelligence is already a gamechanger in healthcare. You’ll learn how AI can be used to develop new drugs and how it can be used to improve patient outcomes e.g. through early diagnostics.

Sign up today to gain new insights and network with peers.

Keywords

  • Gene therapy e.g. CRISPR
  • Stem cell therapy
  • RNA therapeutics
  • Precision medicine
  • AI in healthcare

Save information for later
Read more

Course leader & lecturers

  • Simon Reuter
    Course leader
    Associate Director, MD, Ph.d.
    Novo Nordisk A/S
  • Jørgen Kjems
    Lecturer
    Professor
    Aarhus Universitet
  • Mads Nielsen
    Lecturer
    Professor of Computer Science
    Københavns Universitet
  • Annette Ekblond
    Lecturer
    Director of R&D, Quality, Regulatory Affairs & Co-founder
    Cell2Cure Aps
  • Rasmus Bak
    Lecturer
    Lektor, Ph.d., Cand.scient.
    Aarhus Universitet
See all

Watch the video

Is this course for you?

The course is for you who work in the public healthcare sector, governmental institutions, the life science industry, or associated entities and have a background in political science, social science, legal, IT & engineering, health science, or economy.

What you will learn

  1. Up-to-date knowledge about state-of-the-art technologies for better or potentially curative patient treatments.
  2. What DNA and RNA technology is and how DNA and RNA are used as drug targets.
  3. The status and usage of stem cell treatments and the future outlook.
  4. How AI can be applied best in healthcare and used in drug development.
  5. The current and future use of precision medicine.

What your company will get

  1. An employee who obtains a solid understanding of the current and future landscape of advanced drug development technologies.
  2. An employee who can contribute to your company’s strategic business development objectives.
  3. An employee who comprehends the broader perspective of patient treament

Course calendar

15 Nov 2024 9:00-16:00
Day 1
  • Introduction
  • Gene therapy, e.g., CRISPR (past, present and future).
  • Stem cells (past, present and future).
  • RNA based therapeutics (past, present and future).
  • AI in drug development/patient treatment (past, present and future).
  • What is precision medicine/personalised medicine (past, present and future)?
  • Wrap up
Practical information

Registration

Registration deadline
1 Nov 2024
Atrium
Lersø Parkallé 101
2100 København Ø
Register
15 Nov
Sometimes things change. This is the expected programme.

Course information

Literature

Prior to the course you get access to mandatory and/or optional readings via your personal Atrium log-in.

Prerequisites

There is no examination for this course.

Course leader

Simon Reuter
Associate Director, MD, Ph.d.
Novo Nordisk A/S

Lecturers

Jørgen Kjems
Professor
Aarhus Universitet
Mads Nielsen
Professor of Computer Science
Københavns Universitet
Annette Ekblond
Director of R&D, Quality, Regulatory Affairs & Co-founder
Cell2Cure Aps
Rasmus Bak
Lektor, Ph.d., Cand.scient.
Aarhus Universitet

You may also be interested in these courses

Want to know more or need help?

Contact Contact Client Manager Ida Salicath at +45 39 15 09 46

Send me a message